Zosano Pharma Corp Deferred Tax Assets, Net of Valuation Allowance
Zosano Pharma Corp had Deferred Tax Assets, Net of Valuation Allowance of $922.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2022-03-17
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $922.00K.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.13M.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.61M.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2021-12-31 | $922.00K 10-K · filed 2022-03-17 |
| 2020-12-31 | $1.13M 10-K · filed 2022-03-17 |
| 2019-12-31 | $1.61M 10-K · filed 2021-03-11 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-25 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-12 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-29 |